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The Perception of Adherence to Cystic Fibrosis Guidelines by Respiratory Therapists in Saudi 
Arabia 
By 
Jameel Zaid Hakeem, BSRT 
(Under the Advisement of Dr. Douglas S. Gardenhire) 
ABSTRACT 
BACKGROUND: Adherence to cystic fibrosis (CF) clinical guidelines play a crucial element in 
the management of respiratory complication associated with CF disease. Despite the importance 
of adherence to CF clinical guidelines, there is a lack of literature in this area of research 
specifically relating to Respiratory Therapists (RTs). Therefore, it is essential to assess the 
perception and adherence level to CF clinical guidelines among RTs in Saudi Arabia. 
PURPOSE: The aim of this study was to assess the adherence level of RTs to CF clinical 
guidelines in Saudi Arabia. METHODS: Data were collected through a descriptive survey using 
questions based on CF clinical guidelines. The survey was emailed to all members of the Saudi 
Society for Respiratory Care (SSRC). Two main dimensions were assessed Knowledge and 
Management of CF disease. Excluded from the study were other healthcare providers and 
students. RESULTS: The total adjusted number of participants was one hundred-sixty-six 
(n=166) out of (N=351) responses. The study response rate was 46.8%. Most participants hold an 
undergraduate degree (BS and AS) 80.1% while 19.9% were graduate. Females accounted for 
30.1% of all participants while males accounted for 69.9%. The study showed 35% of RTs in 
Saudi Arabia adhered to CF clinical guidelines. The study showed knowledge domain needs 
improvement compared to management domain (Mdn = 2), Z = -10.45, p < .001, rs = 0.49. The 
study findings showed the level of RT education did not have a significant effect on the level of 
adherence to CF clinical guidelines H(2) = 2.7, p = .255. Moreover, the study findings indicated 
that senior RTs (with > 5 years of experience) demonstrated a higher adherence level to the 
guidelines than RTs with less than 5 years of experience (Mdn = 8.7), U = 2056, p < .001, rs 
=0.314. Additionally, the study revealed no significant difference in adherence of the guidelines 
between regions of practice in Saudi Arabia, H(4) = 2.5, p = .645 Conclusion: The average 
overall level of adherence to CF clinical guidelines is low among RTs Saudi Arabia. Education 
materials need to be implemented to enhance the level of awareness, knowledge, and 
management of CF disease. 
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CHAPTER I 
Introduction 
Cystic Fibrosis (CF) is a multisystem autosomal recessive disorder induced by mutations 
in the gene for the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR encodes 
an ion channel protein, with more than 2000 mutations classified to date (Farrell et al., 2017). 
Two regular copies of the CFTR gene is present in people without CF. A mutation causes CF to 
develop when one of the copies is not working correctly, or both copies not present. CFTR 
functions as a chloride channel regulator, bicarbonate regulator, and chloride and sodium 
transporter through body organs like the lung, pancreas, salivary glands, and kidney. A mutation 
in the gene will lead to a significant effect in both the lung and the gastrointestinal tract. The 
inactivation of CFTR in the lung will disable sodium absorption and chloride transportation over 
airway epithelial cells. This impaired mechanism of transport causes an increase in water 
absorption and a reduction in the total fluid in the airway surface, which leads to a thick, viscous 
sputum in the airway. As the result of the dry airway and sticky mucus, the cilia in CF patient is 
impaired, which can produce a desirable environment for bacterial growth (Boucher, 2007).  
According to the Cystic Fibrosis Foundation yearly reports, about 60,000 to 70,000 
individuals Worldwide suffer from cystic fibrosis (Banjar & Angyalosi, 2015). The worldwide 
incidence varies from country to another. In European countries, the mean prevalence of CF 
disease is 0.737 per 10,000 (Farrell, 2008). In the United States, cystic fibrosis occurs at a rate of 
1 in 4,000 births (Farrell et al., 2017) and 1 in every 5,800 births in Middle East region (Banjar 
& Angyalosi, 2015). 
In Saudi Arabia, the ratio of CF incidence increased from 1 every 2000 to 18 per 1000 
births (Banjar & Angyalosi, 2015). The mean survival rate of cystic fibrosis increased to 20 
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years in Saudi Arabia (Banjar & Angyalosi, 2015). Early diagnosis and management of diseases 
accompanied by effective therapeutic options delivered by multidisciplinary teams has been 
showed to increase the survival rate among CF patients (Spoonhower & Davis, 2016). 
Management of respiratory complication plays an influential role in CF disorder. It 
includes the administration of antibiotics, chest physiotherapy, and airway clearance medication 
such as bronchodilators, Pulmozyme, and hypertonic saline. Therefore, Respiratory Therapists 
must adhere to the updated CF guidelines and stay up to date on treatment options to provide the 
best care to the patient. (Newton, 2009). 
Respiratory therapists (RTs) interact with CF patients in the outpatient clinic and during 
hospitalization. By following the CF pulmonary guidelines, RTs administer aerosol therapy and 
airway clearance to CF patients. They educate patients and families about airway clearance 
techniques and how to prepare and deliver the required treatment. The RTs needs to have the 
enough experience to help them decide when to switch the patient from simple oxygen therapy 
as lung function declines to chronic oxygen, noninvasive ventilation, or to invasive ventilation 
where the end-stage patient waits for a lung transplant. Furthermore, RTs may perform a 
pulmonary function testing to assess patient’s lung function baseline (Newton, 2009). 
Several studies have previously investigated the lack of adherence and implementation of 
clinical guidelines among health care providers in health care facilities (Francke, Smit, de Veer, 
& Mistiaen, 2008).  Additionally, there is limited research regarding cystic fibrosis clinical 
guideline adherence globally. In Saudi Arabia, the mean survival rate improved from ten years to 
twenty years (Banjar, 2003), (Banjar & Angyalosi, 2015). To maintain this increase, the health 
care provider should follow and apply the new guidelines. Therefore, this study aims to 
investigate adherence level of RTs to the clinical care guidelines for the management of 
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respiratory complications in cystic fibrosis patients in Saudi Arabia. 
Statement of Problem 
 The majority of cystic fibrosis mortality cases and hospital admission are due to 
pulmonary exacerbation (Agrawal, Lalani, Alagusundaramoorthy, & Du, 2016). In Saudi Arabia, 
which has the highest rate of CF cases among Arab countries (Banjar, 2003), the mean survival 
rate of cystic fibrosis patients is lower than other countries like United States. Between 1998 and 
2013, the rate of hospital admission due to pulmonary exacerbation and cost of care in CF 
patients increased by 75%. Since RTs play a significant role in the managements of pulmonary 
complications in cystic fibrosis (CF), they are expected to have adequate information about the 
disease and its management.  
Purpose of the Study 
 This descriptive quantitative study aims to assess the adherence level of Respiratory 
Therapists (RTs) to cystic fibrosis (CF) guidelines and determine if the RTs in Saudi Arabia are 
following the CF Foundation’s guidelines for the management of respiratory complication in CF 
disease. The research will also show the weak point that needs to be improved in CF awareness 
and management. Moreover, the research will show if the adherence is one of the reasons for 
increasing the survival rate in the Saudi Arabia. The research questions are going to be addressed 
in this study are: 
1. What is the level of adherence among Respiratory Therapists (RTs) in Saudi Arabia to 
cystic fibrosis (CF) clinical guidelines? 
2. Which section (awareness or management) needs most improvement in terms of level of 
adherence to CF clinical guidelines?  
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3. What is the effect of the level of RT’s education on the level of adherence to CF clinical 
guidelines?   
4. What is the level of adherence to CF clinical guidelines in senior RTs compared to junior 
RTs? 
5. What is the level of adherence among RTs between the different regions of Saudi Arabia? 
Significance of the Study 
 The study will contribute to improving knowledge and adherence of respiratory staff to the 
cystic fibrosis clinical guidelines.  The study will also establish a solid foundation that helps to 
improve the adherence of Respiratory Therapists with international CF guidelines and make 
visible areas of practice that may require more training and education in future. Moreover, the 
study will show the level of adherence to the published guideline among RTs. This information 
will improve the quality of CF patient care and survival rate. 
Assumptions 
The following assumptions are made regarding this descriptive study:  
1.Respiratory therapists who follow published guidelines demonstrate more skill when caring 
for CF patients (Newton, 2009). 
2.Adherence to the CF clinical guidelines minimizes the length and cost of hospital admission 
(Agrawal, Lalani, Alagusundaramoorthy, & Du, 2016). 
3. The rate of pulmonary exacerbation for CF patients decreases if the respiratory therapist 
adheres to CF guidelines.  
4.Senior RTs have less adherence to CF guidelines compare to junior RTs. 
5.RTs have the same adherence to CF guidelines in all the regions of Saudi Arabia. 
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Definition of Terms 
Cystic Fibrosis (CF): An inherited progressive disease that affects the lungs and digestive 
system. 
Cystic fibrosis transmembrane conductance regulator (CFTR): Gene controls the transportation 
of anions, regulate chloride concentration in epithelial cells. 
Respiratory therapists (RTs): healthcare provider specialized in working therapeutically with 
people suffering from pulmonary disease. 
Limitations 
The study uses different conclusions drawn from various participants’ educational 
degree, the duration of their experience, and educational programs, which may add to the 
significance of the study findings. However, the findings of this study cannot be generalized to 
all RT due to the use of only one destination of experience, and one cultural background, Saudi 
Arabia. 
Delimitations 
This study included a population of Respiratory Therapists from different regions in 
Saudi Arabia. The results of this study can only be generalized to this group of therapists. Data 
from the respiratory therapists will be utilized to satisfy the research questions. To prevent errors, 
it excludes respiratory therapy students and other healthcare providers. 
Summary 
One of the respiratory therapy care goals is to provide outstanding care to CF patients. The 
professional knowledge, compliance, and adherence to cystic fibrosis patient care guidelines is 
essential to CF management. The rate of pulmonary complications, hospital admissions and 
mortality rate among CF patients is a good indicator of the quality of care that has been provided 
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by the therapist. Therefore, the knowledge of and adherence to published clinical practice 
guidelines for care of the CF patient need to be both identified and evaluated.  
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CHAPTER II 
Review of the Literature 
The following literature reviews illustrates a detailed analysis of the works that have been 
accomplished by other researchers and which are related to the importance of knowledge and 
adherence of the health care provider to clinical guidelines in the management of respiratory 
complication in cystic fibrosis disease (CF). The primary purpose of this literature review is to 
help the researcher expose the research gap present in this area of research and hence provide a 
possible solution to bridge it. The chapter is divided into sections namely: background of cystic 
fibrosis, prevalence and diagnosis of CF, CF in Saudi Arabia and the role of respiratory therapy 
in CF management. Other areas that will be reviewed are the importance of adherence and 
compliance among health professionals to the clinical guidelines and the impact of high 
knowledge and adherence of the health care provider in disease management and cost relation. 
Finally, it will take a look at the Management of Respiratory Complication in CF. 
Databases used for this review include; PubMed, EBSCOhost, Google Scholar, and 
CINHALL.  The following keywords used mutually; “cystic fibrosis,” “cystic fibrosis 
management,” “cystic fibrosis respiratory complication,” “cystic fibrosis epidemiology’, “the 
importance of adherence to published guidelines” “cystic fibrosis survival range,” “cystic 
fibrosis management cost.” The research finding showed a variety of publication that shows 
cystic fibrosis management and epidemiology. However, there is insufficient research in the area 
of measuring the adherence level of the Respiratory Therapists to published guidelines.  
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Background Information on Cystic Fibrosis 
Cystic Fibrosis (CF) has been a cause of concern to medical practitioners from all parts of 
the world. In 1938, Dorothy Andersen identified CF as a separate disease after her autopsy 
studies of malnourished infants (Dean et al., 1990), (Davis, 2006).  Henceforth, it has caused a 
lot of havoc to the human especially in Europe and North America (Farrell, 2008). CF is 
described as an autosomal genetic disorder that causes severe impact on the pulmonary tract, 
digestive system and other body organs (Salinas et al., 2016). The leading cause of CF is the 
mutation of a gene that alters the functionality of chloride-conducting transmembrane dubbed the 
cystic fibrosis transmembrane conductance regulator (CFTR) which controls the transportation 
of anions, regulate chloride concentration in epithelial cells and enhances clearance of mucus in 
the respiratory tract (Berwick, Nolan, & Whittington, 2008). CFTR failure cause a retention of 
thick, tenacious secretion in the pulmonary system, and this can lead to airway inflammation 
caused by the growth of the bacteria in the retained secretion (Salinas et al., 2016). CF also 
affects other body organs like pancreas causing malabsorption, liver resulting in biliary cirrhosis, 
vas deferens causing infertility and sweat glands leading to heat loss (Oliver, Cantón, Campo, 
Baquero, & Blázquez, 2000). However, most of the morbidity and mortality occurs due to 
bronchiectasis, obstruction of small airways, and progressive impairment of the respiratory 
system (Stephenson et al., 2017).  
Prevalence and Diagnosis of Cystic Fibrosis 
Studies indicate that CF is one the most common diseases in the United States of 
America with over 1,000 cases reported annually. It approximated that over 30,000 people in the 
United States are affected and 70,000 globally (Earley et al., 2011). However, the CF prevalence 
varies among the ethnic groups of the population. In the USA, the Caucasian Americans are most 
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prevalent with 3 per 10,000 followed by African Americans at 7 per 100,000 and finally the 
Asian Americans with 3 per 100,000 (Earley et al., 2011). This information also varies due to the 
discrepancies in reporting systems and the presence of the unreported cases in the country 
(Berwick, Nolan, & Whittington, 2008). The diagnosis of the CF comprises some laboratory and 
clinical tests which include evaluation of the presence and amount of chloride channel 
dysfunction (Earley et al., 2011).  
Sweat test is considered the gold stander to diagnose CF (Tümmler, 2017). A chloride 
concentration of 60 mmol/L or more in the sweat led to a positive diagnosis of CF (Raina et al., 
2016). For the test to be reliable, it must be conducted by experienced technicians in facilities 
where the national standards are applied (LeGrys, Yankaskas, Quittell, Marshall, & Mogayzel, 
2007). Because some CF patients have  normal chloride concentrations, sweat chloride tests 
needs to be ≥ 60 mmol/l on two occasions to confirm the diagnosis of the disease (Raina et al., 
2016). Other assessment strategies that may be helpful when diagnosing CF includes the 
assessment of gallbladder function, evaluation of liver, signs of intestinal obstruction, nasal 
potential difference measurement, or pansinusitis identification and a close inquiry into the 
family history (Kacmarek et al., 2009).  
Genotyping is usually conducted to facilitate identification of the pancreatic malfunction 
of the gene on chromosome seven responsible for encoding of CFTCR (Earley et al., 2011). 
Despite symptoms analysis being the most common diagnosis approach to this disease, infant 
screening took precedence in the United States to provide an early intervention (Parker-McGill et 
al., 2015). According to the Cystic Fibrosis Foundation Patient Registry in the United States, 
children are screened for CF at birth and majority of the cases are diagnosed before the age of 
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two. However, some of the CF cases are diagnosed at adult age where a doctor orders a genetic 
and a sweat test to confirm the diagnosis whenever there is suspicion of the condition.  
Cystic Fibrosis in Saudi Arabia 
CF has existed in the Middle East for approximately half century and has caused 
concerns to the health practitioners in the region (Banjar, Moghrabi, Alotaibi, Alotaibi, & 
Gamalmaz, 2017). The incidence rate of CF among the natives Arab is markedly high as 
compared to the non-natives. In Jordan, the incidence of CF is 1 in 2500 of all the live births. 
This is followed by Bahrain which has an incidence of 1 in 5000 live births (Banjar, Kambouris, 
Meyer, al-Mehaidib, & Mogarri, 1999). The first CF case in the Middle East was reported in 
1958 in Lebanon, where the first CF case in gulf courtiers was report in 1977 in Kuwait (Banjar, 
Moghrabi, Alotaibi, Alotaibi, & Gamalmaz, 2017). In Saudi Arabia, the first CF case was 
identified in 1986 and the condition continues to be a significant threat to the lives of Saudi 
citizens (Banjar, Moghrabi, Alotaibi, Alotaibi, & Gamalmaz, 2017).  
Despite the challenge of determining the prevalence of CF in the Middle East. The 
prevalence of CF in Saudi Arabia CF has been projected to range between 1 in 30,000 to 1 in 
50,000 (Banjar & Angyalosi, 2015). Similarly, determination of the magnitude of incidence of 
CF among Saudi Arabia (SA) population has become elusive. The figures provided are mere 
approximations, and these indicate that it lies between 1 in 2000 and 1 in 5800 live births per 
year (Banjar & Angyalosi, 2015). The determination problems are associated with the 
overlooked of CF disease with other conditions, such as tuberculosis, diarrheal diseases and 
malnutrition (Banjar, Moghrabi, Alotaibi, Alotaibi, & Gamalmaz, 2017), According to Banjar, et 
al. (2017) the mean survival rate of CF patients in Saudi Arabia is estimated to be 20 years. 
Studies attribute this low survival rate to the delay in the diagnosis and lack of sufficient 
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awareness of the disease in the region (Farrell et al., 2017). This situation has resulted in late 
intervention which increases the risks of the early patient deaths (Kacmarek et al., 2009). 
 Saudi Arabia has a variant distribution of CF among its population by sex, geographical 
location and ethnic alienation (Nazer et al., 1989). In a study to determine the geographical 
distribution of CF in the country, 70 patients were identified, and 37% of this sample was found 
to come from the eastern parts of SA (Banjar, Kambouris, Meyer, Al-Mehaidib, & Mogarri, 
1999). The central region contributed 28%, western region 22%, northern 5% and the southern 
8% of the patients (Nazer et al., 1989). CFTR mutations were found in 33 families of which 67% 
were originally from Saudi Arabia while 13% were nonnatives (Banjar, Kambouris, Meyer, Al-
Mehaidib, & Mogarri, 1999). Moreover, a study aimed at characterizing CFTR a gene mutation 
that led to CF in Saudi Arabia. The study found that 1234V and 1548deIG are the most common 
types of mutations in Saudi Arabia (Banjar, Kambouris, Meyer, al-Mehaidib, & Mogarri, 1999). 
Role of Respiratory Therapy in Management of CF 
A 1988 study showed that respiratory therapy is one of the critical interventions in the 
management of CF and the associated comorbidities (Abman, Ogle, Butler-Simon, Rumack, & 
Accurso, 1988). Different scholars have suggested various treatment methods of managing CF 
disease. Among the most commonly used therapies in controlling CF are gene replacement 
therapy, airway clearance to mobilize the sputum from the respiratory airway and the use of 
aerosol drugs help to expectorate sputum and prevent the chance of infections (Abman, Ogle, 
Butler-Simon, Rumack, & Accurso, 1988). However, no particular method has been touted to be 
the best in managing CF. The main question is what is the role of Respiratory Therapist (RT) in 
controlling this disorder (Volsko, 2009). Geller and Rubin (2009) argue that RT has played a 
central role in CF management for a very long time and is vital in the management of CF among 
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patients (Volsko, 2009). The main goals of respiratory therapy is clearing the airway and 
improve oxygen intake by patients (Volsko, 2009). Respiratory therapists have significant roles 
in taking care of inpatient and outpatient CF patients (Volsko, 2009). RTs are responsible for 
offering education to CF patients on airway clearance techniques such as; cough & huff 
technique, chest physiotherapy (CPT), oscillating positive expiratory pressure (Oscillating PEP), 
positive expiratory pressure (PEP) therapy, active cycle of breathing technique and autogenic 
drainage (AD) (Wilson, Agnew, Morrison, Akinyede, & Robinson, 2014). They also administer 
aerosols therapy to patients. RTs conduct research to identify new devices and techniques for 
controlling CF symptoms (Volsko, 2009) However, despite studies highlighting the role of the 
RTs, very few have addressed the impact of CF to them. It is observed that RTs takes a lot of 
pride in successfully guiding a patient out of CF, and therefore they take their work as a 
motivating factor (Volsko, 2009).  
The Importance of the Adherence and Compliance among Health Professionals to 
the Clinical Guidance 
The primary significance of compliance and adherence to the set clinical guidelines 
among health professionals is bridging the gaps between the management of disease and improve 
the disease outcomes. All professions have their underlying operation standards and principles 
that regulate their actions and behaviors. The healthcare profession is one such sector where the 
staffs are expected to strictly adhere to the set guidelines when dealing with patients considering 
that life is a sensitive matter (Brusamento et al., 2012). Compliance and adherence to the clinical 
guidelines by these professions are crucial in determining the outcome of the treatment process 
(Singh, Rebordosa, Bernholz, & Sharma, 2015). Based on bioethics principles, the healthcare 
professional should ensure that the patient has autonomy in deciding whether to take the 
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prescribed medication or not (Geller & Rubin, 2009). Moreover, any decision taken by the 
healthcare professional should the most beneficial to the client and at the same time maintains 
the confidentiality of the patients’ medical information (Wahl et al., 2005). Adherence to these 
guidelines is not only important to the healthcare professional but also to the wellbeing of the 
patient (Brusamento et al., 2012). If the prescription is not appropriately done, the patient may 
end up failing to follow it, and this may result in increased cases of disease exacerbation and 
hospital admission (Morgan et al., 1999). On the side of the healthcare professional, failure to 
adhere to the prescribed guidelines when offering services to clients may lead to prosecution 
especially if the outcome is death or deterioration of the patient after treatment (Geller & Rubin, 
2009). Moreover, lack of compliance with the medical procedures and guidelines may result in 
health hazards to both the healthcare professional and the client (Singh, Rebordosa, Bernholz, & 
Sharma, 2015). For communicable diseases, the reliant on personal protective equipment (PPEs) 
and ignoring clinical guidelines may expose health care practitioners to the risk of contracting 
the disease (Brusamento et al., 2012). It is therefore vital for all healthcare professionals to 
strictly follow the provided clinical guidelines in ensuring that they are safe, and the patients 
obtain the most suitable outcome of the treatment process (Strausbaugh & Davis, 2007).  
In conditions such as CF where the management keeps improving due to the various 
advancements and breakthroughs in management, it is crucial for all healthcare professionals to 
be up to date with the current protocols of treatment to provide high quality care (VanDevanter, 
Kahle, O’Sullivan, Sikirica, & Hodgkins, 2016). High-quality care for such conditions can be 
provided if the healthcare professionals are using up to date techniques per the most recent 
guidelines. It is essential to establish methods and strategies like guideline dissemination, 
education, audit and feedback, and academic detailing to help the health professionals who have 
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been in the field for many years to adapt and adhere to the newly published guidelines (Jeffery et 
al., 2015).  
The Relationship Between Knowledge and Adherence to Disease Management and Cost  
Healthcare professionals have become more effective in the health service delivery with 
increasing period of practice (Geller & Rubin, 2009). It is believed that the longer the duration of 
service and individual has, the more experience and knowledge they gather on the treatment 
procedures and hence they become better practitioners (Strausbaugh & Davis, 2007). However, 
as much as this statement may hold some basis, it may not always be the case (Choudhry, 
Fletcher, & Soumerai, 2005). Choudhry et al, (2005), in a systematic review of 32 studies, stated 
67% of them demonstrated a negative association between the age of the physicians and their 
performance (Choudhry, Fletcher, & Soumerai, 2005). The result of the study shows experience 
and knowledge to the clinical guidelines is not the only factor that determines the quality of care 
delivered by healthcare professionals (Choudhry, Fletcher, & Soumerai, 2005). Refreshing 
knowledge can provide additional methods and treatment of various disease conditions (Earley et 
al., 2011). It supports the redesigning of primary care, population health management and other 
systems that improve health care results (Brusamento et al., 2012). The development of 
knowledge in the treatment of cystic fibrosis has dramatically increased the evolution of disease 
management. 
Adherence to the recent published guidelines and set regulations in the medical sector is 
crucial in cost reduction since it minimizes the probability of repeat therapy for patients 
(Choudhry, Fletcher, & Soumerai, 2005). It improves knowledge and experience of disease 
management which can reduce the cost of disease management and make healthcare affordable 
to all individuals in the society (Karbach et al., 2011). Additionally, strictly following the clinical 
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procedure when operating medical equipment and machines reduces the chances of misuse and 
malfunctions of the equipment’s which is an essential portion in cost cutting and decrease the 
repair expenses in the healthcare facilities (Modi et al., 2006). Several Studies indicate that 
proper mastery of the clinical requirement is essential in improving disease management and cost 
relative (Spruit et al., 2013). With the right knowledge of the treatment procedure, healthcare 
professionals will offer proper intervention to the patient irrespective of the experience in the 
field (Modi et al., 2006). Adequate skills also cut down the cost of training health care providers 
(VanDevanter, Kahle, O’Sullivan, Sikirica, & Hodgkins, 2016). However, experience cannot be 
totally written off regarding the performance of clinicians as it provides familiarity with the 
symptoms of a specific disorder thereby and speeding up the process of diagnosis (Richards, 
Lester, Chin, & Marshall, 2013). Therefore, it is essential to consider methods that can measure 
the adherence and knowledge of healthcare provider to published guidelines.  
 Management of Respiratory Complications in Cystic Fibrosis 
Various intervention and techniques have been put forward to manage CF, on among 
them is the CF airway clearance therapy (ACT) (Mogayzel et al., 2013). This method applied 
because, despite CF affecting many organs in the body, almost 85% of the total mortalities are 
caused by lung infections (Gibson, Burns, & Ramsey, 2003). It has been suggested that cleaning 
the airway of the mucus secretion along the respiratory tract is necessary for reducing the 
obstruction of the air path and at the same time minimize lung infections and inflammations 
(Gibson, Burns, & Ramsey, 2003). Despite being one of the most basic intervention plans, ACT 
is not sufficient as single intervention with CF management, and therefore there is a need to 
consider other methods of controlling CF (Schluchter, Konstan, Drumm, Yankaskas, & Knowles, 
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2006). However, ACT has been found to reduce exacerbations among patients and improve lung 
functions (Gibson, Burns, & Ramsey, 2003). 
Pulmonary exacerbations refer to worsening of lung functioning and respiratory tract 
blockage as a result of acute CF (Mogayzel et al., 2013). This situation is usually characterized 
by increased sputum production, persistent coughs, chest pains, and shortness of breath and lung 
dysfunction among other symptoms (Flume et al., 2009). A study by pulmonary disorder 
specialists has suggested various treatments for managing pulmonary exacerbations among 
patients (VanDevanter, Kahle, O’Sullivan, Sikirica, & Hodgkins, 2016). One of these techniques 
is the prescription of appropriate antibiotics (Flume et al., 2009). However, the committee 
recommends the use of inhaled tobramycin antibiotics for Pseudomonas aeruginosa bacteria 
since it is the primary cause of respiratory infections (Oliver, Cantón, Campo, Baquero, & 
Blázquez, 2000). There should be a lot of caution to ensure that the right dosage is prescribed 
and this treatment is best suited for inpatient intervention (Flume et al., 2009). Apart from 
antibiotics, ACT is another alternative to dealing with pulmonary exacerbations. Chest 
physiotherapy is another crucial treatment for CF (Richards, Lester, Chin, & Marshall, 2013). 
This method is suitable for reducing the level of secretion in the lungs and the rest of the 
respiratory tract (Flume et al., 2009). The intervention involves postural drainage, deep breathing 
exercise, chest percussion, and vibration and coughing (Waters & Smyth, 2015).  
For acute cases of CF, chronic medications are recommended, however under strict 
guidelines. First of all, the prescription has to be done by highly knowledgeable and experienced 
physicians (Elborn et al., 2016).In some circumstances, it is typical for people suffering from 
constant CF to experience significant lung injury; this condition is referred to as pneumothorax 
(Elborn et al., 2016). Moreover, some patients may end up coughing blood from the lungs a 
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situation called hemoptysis (Razvi et al., 2009). The CF Foundation provides a guideline for 
managing these two pulmonary complications which include hospital admission (Flume et al., 
2010). In addition to the hospitalization, the patients should be offered ACT, inhaled 
medications, and antibodies prescribed (Flume et al., 2010). Furthermore, a patient experiencing 
large or tension pneumothorax should be undertaken through chest tube replacement, or 
pleurodesis for patients who have experienced pneumothorax a couple of times (Elborn et al., 
2016). The affected individual should also be given a chance to relax to restrict physical 
activities which may increase the oxygen consumption rate, thus promoting chances of 
suffocation (Schluchter, Konstan, Drumm, Yankaskas, & Knowles, 2006). 
Summary  
Cystic Fibrosis is a deadly disease and is a concern for all health care providers all over 
the world. The prevalence of CF varies from one country to another, even though it is highest 
among the Non–Hispanic White Americans. If diagnosed early enough, CF can be managed. 
However, delayed reporting reduces the survival rate significantly. Various treatments are used 
to manage CF and related disorders. The literature review proves that the most effective 
intervention is the ACT and use of antibiotics even though chest physiotherapy has also has 
worked for some patients. CF management strategies in Saudi Arabia have improve the survival 
rate and management of the disease. 
 18 
 
 
CHAPTER III 
Methodology 
In this study, the researcher investigated the adherence level of Respiratory Therapist 
(RTs) to the cystic fibrosis (CF) clinical care guidelines for the management of respiratory 
complications in cystic fibrosis patient in Saudi Arabia.  
The committee members met and discussed every element of the instrument and finalized 
a survey of thirty questions (see appendix A). To gather data for this study, an online survey is 
distributed through the Saudi Society for Respiratory Care (SSRC) to all its registered members. 
Participants’ responses are going to be filtered based on the study inclusion and exclusion 
criteria. This chapter explains the methods and procedures that are going to be used to conduct 
this study. 
 Research Questions 
The study set out to answer the following questions: 
1. What is the level of adherence among Respiratory Therapists (RTs) in Saudi Arabia to 
cystic fibrosis (CF) clinical guidelines? 
2. Which section (awareness or management) needs most improvement in terms of level of 
adherence to CF clinical guidelines?  
3. What is the effect of the level of RT’s education on the level of adherence to CF clinical 
guidelines?   
4. What is the level of adherence to CF clinical guidelines in senior RTs compared to junior 
RTs? 
5. What is the level of adherence among RTs between the different regions of Saudi 
Arabia?   
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Instrumentation 
The instrument developed in this study is based on the Cystic Fibrosis Foundation’s 
published guidelines. All the multiple-choice questions were taken based on the suggestion and 
recommendation of the CF clinical guidelines. A committee of respiratory therapy education 
experts consisting of The Director of Respiratory Therapy Program, The Director of Clinical 
Education, and an assistant clinical professor implemented a modified Q-sort method. A Q-sort 
method has each member on the panel “sort” each question into piles for categorization (Block, 
1961). 
Validity and reliability refer to the consistency and precision of the used instrument. 
Reliability expresses to the researchers if they achieve consistent scores from the tools, where 
validity will tell them if the score has any meaning. Validity describes the extent to which a tool 
measures what it is supposed to measure (Burns & Grove, 2005). A panel of respiratory therapy 
education experts discussed the instrument thoroughly and apply content validity. From this 
meeting, the committee agreed on the elimination of seven unclear items. The rest of thirty-three 
items were carefully reviewed, reworded and formatted for better clarity. 
The finalized instrument for this study consists of two parts, demographic data, and the 
survey. The demographic section consisted of fill in the blank and multiple-choice questions 
regarding gender, age, country and region of residence, the highest level of education, age upon 
start working as respiratory therapist, years of experience in the field of respiratory care, highest 
completed overall level of education, clinical experience with CF patient and guidelines, current 
position and National Board for Respiratory Care (NBRC) accreditation. Part II, emphasizes on 
measuring and assessing the amount adherence of the respiratory therapist to the Cystic Fibrosis 
foundation published guidelines. These dimensions are: RTs perception and knowledge of CF 
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disease (6 questions) and RTs Perception of CF disease management (14 questions). The 
instrument can be found in appendix A. 
Research Design 
A study of descriptive exploratory research design with a self-reporting survey is going to 
be used in this study. A survey is a technique of research that comprehends answering questions 
or interviews (Brown, 2009). The aim of a survey is using questionnaire interviews to gather data 
from a sample to describe the population in research. The survey design used in this study intended 
to collect data from the respiratory therapist members of SSRC. The ability to collect a large 
amount of data from many participants by using a single instrument is one of the advantages of 
using survey research. Also, survey research includes lower cost with the use of online 
technologies and reaching a large number of participants (Portney & Watkins, 2008). 
Sample 
A convenience sample will be used in study and the subjects chose criteria will depend 
on the basis of their availability. The study group will be the members of Saudi Society for 
Respiratory Care (SSRC). The SSRC is a scientific non-profit association that aims to promote 
and advances the profession of respiratory therapy in Saudi Arabia through sponsoring of 
scientific activities throughout all regions of the kingdom (SSRC, 2015). Permission from SSRC 
is required to survey all members in its database utilizing an electronic approach. The 
participants will be provided with 33 questions with a cover letter explaining the purpose of the 
study and assuring them of confidentiality.  
To be precise in answering the research questions, respiratory therapists (RTs) who deal 
with cystic fibrosis disease (CF) in Saudi Arabia will be included in the study. RTs from other 
countries, RTs who have not treated CF patients in the past, or RTs who are not familiar with CF 
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disease will be included in the study. RTs students and other healthcare providers will be 
excluded from the study. 
Data Analysis 
Data was transferred to the Statistical Package for the Social Sciences (SPSS) version 25. 
Descriptive statistics including mean and standard deviation were obtained for age, years of 
experience and starting age while frequency, percentage and mode were obtained for gender, 
country of practice years of experience (less than five years or five years or more), region of 
practice in Saudi Arabia, highest level of respiratory therapy education, highest completed 
overall level of education, current position, familiarity with CF treatment and guidelines and 
credentialed from NBRC. Spearman’s rank correlation analysis was used to identify the 
relationship between current age and number of correct responses for awareness section, current 
age and number of correct responses for management section, and current age and number of 
correct responses for both sections overall. Mann-Whitney U-Test was used to compare the 
differences in number of correct responses for awareness section, management, and both sections 
overall between gender, current practice, years of experience (less than five years or five years or 
more), year of practice, familiarity with CF treatment & guidelines, and credentialed from 
NBRC.  Kruskal-Wallis Test was used to compare the difference in the number of correct 
responses for awareness, management, and both sections overall between, region of practice in 
Saudi Arabia, highest level of respiratory therapy education, highest completed overall 
education, and current position. The magnitude of correlations between variables in Spearman’s 
rank correlation analysis will be interpreted using Davis conventions (Davis, 1970).  
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Coefficient Description 
.70 or higher Very strong association 
.50 to .69 Substantial association 
.30 to .49 Moderate association 
.10 to .29 Low association 
 
Protection of Human Subjects 
The study proposal will be submitted to Georgia State University Institutional Review 
Board (IRB) for expedited approval. Procedures for protection of human subjects will be strictly 
implemented. Study participation will be voluntary with consent assumed on the return of a 
completed survey. Confidentiality will also be protected and surveys were anonymous. In 
addition, using an online survey approach meant that participation did not have to use email to 
submit the participants’ responses, thus avoiding indirect identification. After all data are 
analyzed, all surveys will be deleted. 
Development of a Cover Letter 
The researcher formed a cover letter after examining formerly published survey examples 
(Portny & Watkins, 2008). The cover letter was sent to the thesis chair for further review and 
examination. The final cover letter and follow-up emails can be seen in appendixes B, C, and D 
sequentially. 
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CHAPTER IV 
FINDINGS 
This study aimed to assess the adherence level of Respiratory Therapists (RTs) to the 
cystic fibrosis (CF) clinical guidelines and determine if the RTs in Saudi Arabia are following 
the CF Foundation's clinical guidelines for the management of respiratory complication in CF 
disease.  Moreover, this study showed the weak point that needs more improvement in CF 
management. This chapter presents the results of the statistical analysis as well as the 
demographic information of the samples. Statistical Package for the Social Sciences 25 (SPSS 
25) was used to conduct the statistical analysis for this study. The findings will be presented 
separately in relation to the following research questions. 
Research Questions 
1. What is the level of adherence among Respiratory Therapists (RTs) in Saudi Arabia to 
cystic fibrosis (CF) clinical guidelines? 
2. Which section needs most improvement in terms of level of adherence to CF clinical 
guidelines?  
3. What is the effect of the level of RT’s education on the level of adherence to CF clinical 
guidelines?   
4. What is the level of adherence to CF clinical guidelines in senior RTs compared to junior 
RTs? 
5. What is the level of adherence among RTs between the different regions of Saudi Arabia? 
Demographic Findings 
The study included a convenient sample of registered members of the Saudi Society for 
Respiratory Care (SSRC). The sample covers respiratory therapists who are currently working or 
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have worked in Saudi Arabia. Three hundred-fifty-one responses were obtained out of 750 
emailed surveys, resulting in a response rate of 46.8%. Out of 351 responses, one hundred-sixty-
six responses were completed, ending up with a completion rate of 47.1%. Student participants 
and other health profession providers were excluded from the study. Moreover, undergraduate 
degree (BS and AS) accounted for 80.1% (n=133) of the participant, while 19.9% (n=33) were 
graduate degree therapist (MS). Meantime, the respiratory therapists’ highest overall levels of 
education in Saudi Arabia, which may or may not include RT education, were as follows: AS 
5.4% (n=9), BS 69.3% (n=115), MS 20.5% (n=34), Doctorate 3.6 % (n=6), and MD 1.2% (n=2). 
The majority 94% (n=156) of the participants were from Saudi citizen while 6% (n=10) were 
from other countries. Also, the male 69.9% (n=116) participants were constituting most of the 
sample, where female participant constitutes 30.1% (n=50) of the sample. 79.5% (n=132) of the 
RTs are currently practicing respiratory care profession in Saudi Arabia(SA), whereas 20.5% 
(n=34) RTs were practicing in SA. Furthermore, 51.8% (n=86) responses were from central 
region, 24.1% (n=40) were from east region, 18.1% (n=30) were from west region and 6% 
(n=10) were from other regions. 
RTs Specialist constituted (n=100) 60.2 % of the responses, were 8.4% (n=14) of the 
responses were from RTs Technicians.  RTs Supervisor responses were (n=14) 8.4% of the 
sample were RTs Director or Manager were 4.8% (n=8) of total responses. RTs Faculty member 
composed 10.8% of responses (n=18) were 4.2% (n=7) of responses were from RTs Clinical 
Educator. Responses from Unemployed were 3% (n=5) of the total response. From the total 
sample, 63.9% (n=106) of therapists have treated CF patient while 36.1% (n=60) haven't treated 
CF in the past. Also, 53.6% (n=89) of the participants were familiar with CF clinical guidelines 
while 46.4% (n=77) were not familiar with CF clinical guidelines. 33.1% (n=55) of the therapists 
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were credentialed register Respiratory Therapist (RRT) by National Board of Respiratory Care 
(NBRC) from the United States of America where 66.9% (n=55) were not credentialed. Mean 
current age score in years and standard deviation (SD) for the participants were (M=29.2, SD ± 
5.5), while mean age score and SD for RTs when they started RT care profession international 
were (M=24.2, SD= ±2.6). Also, mean score and SD for years of experience in RT field were 
(M=4.93, SD= ± 4.9). 
 
 
 
 
 
 
 
Table 1 – Demographic Characteristics of Respiratory Therapists in Saudi Arabia. N=166 
Characteristic N % 
Country of Citizenship   
Canada 3 1.8 
Philippines 4 2.4 
Saudi Arabia 156 94.0 
United States of America. 2 1.2 
Yemen 1 0.6 
Gender   
Male 116 69.9 
Female 50 30.1 
Table 2 – Demographic Characteristics of Respiratory Therapists in Saudi Arabia. N=166 
Characteristic M SD Minimum Maximum 
Current age 29.2 ±5.5 23 51 
Age when started respiratory care profession (yrs.) 24.2 ±2.6 20 39 
Years of experience 4.93 ±4.9 0 22 
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Table 3 – Educational and Professional Characteristics of Respiratory Therapists in Saudi 
Arabia. N=166
Characteristic  N % 
Practicing respiratory care in Saudi Arabia   
Yes 132 79.5 
No 34 20.5 
Region of Practice   
Center  86 51.8 
East  40 24.1 
North  2 1.2 
South  8 4.8 
West  30 18.1 
Level of Respiratory Therapy Education   
Associate degree 11 6.6 
Bachelor’s degree 122 73.5 
Master’s degree 33 19.9 
Overall level of Education   
Associate degree 9 5.4 
Bachelor’s degree 115 69.3 
Master’s degree 34 20.5 
Doctorate (PhD, EdD, ScD, etc.) 6 3.6 
Doctor of Medicine 2 1.2 
Position   
Technician 14 8.4 
Specialist 100 60.2 
Supervisor 14 8.4 
Director or Manger 8 4.8 
Clinical Educator 7 4.2 
Participant treated a cystic fibrosis (CF) patient in the past   
 Yes 106 63.9 
No 60 36.1 
Familiarity with CF foundation clinical guidelines   
Yes 89 53.6 
No 77 46.4 
Credentialed RRT from NBRC   
 Yes 55 33.1 
 No 111 66.9 
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Missing Data  
 All the incomplete responses were not use in the study. Out of 254, (N=166) responses 
were used in this study. Also, 7 participants were excluded because they disagreed to participate.  
Findings Related to Research Question 1 
The first research question asked, “What is the level of adherence among Respiratory 
Therapists (RTs) in Saudi Arabia to cystic fibrosis (CF) clinical guidelines?”. Median, Mode, 
and percentages were calculated and tabulated for each research question in the survey (see 
tables 4-1 and 4-2). Also, Median, Mode, and percentages were calculated for number of correct 
responses overall (see table 4-3). Out of 20 questions measuring knowledge and management, 
most number of people (mode=6, n=25) answered 30% of questions correctly. On average, 
respondents answered 35% of questions correctly (median=7, n=16). So, the average level of 
adherence among RTs in Saudi Arabia to CF clinical guidelines is 35%.  
Findings Related to Research Question 2 
The second research question asked, “Which section needs most improvement in terms of 
level of adherence to CF clinical guidelines?” A Wilcoxon Signed-ranks test indicated that 
significantly more questions were answered correctly for the management section (Mdn = 5) than 
awareness & knowledge section (Mdn = 2), Z = -10.45, p < .001, rs = .49 (see table 5 
Comparison of level). Respondents performed worse in the knowledge section than the 
management section.  
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0= Wrong answer, 1= Right answer, 2 = I don’t know                                          
Table 4-1 – Descriptive statistics for knowledge section. N=166 
Question Correct % (n) Wrong % (n) I don’t know % (n) Mode Median 
Awareness and knowledge of CF       
From my experience as a Respiratory Therapist, sweat chloride of ……... mmol/l or more can indicate the 
presence of CF. 42.8 (71) 17.5 (29) 39.8 (66) 1 1 
From my experience as a Respiratory Therapist, performing direct spirometry test for an adult patient with 
CF disease, the predicted value for forced exhaled volume in 1 second (FEV1) will be ……… 10.8 (18) 71.1 (118) 18.1 (30) 0 0 
From my experience as a Respiratory Therapist, most CF chest x-ray demonstrate ………. ….. lungs. 28.3 (47) 59.6 (99) 12.0 (12) 0 0 
From my experience as a Respiratory Therapist, CF inflammatory response is ……......relative to the 
burden of infection. 67.5 (112) 12.0 (20) 20.5 (34) 2 1 
From my experience as a Respiratory Therapist, ……………... is the most common destructive airway 
pathogen present in CF patients. 36.1 (60) 22.9 (38) 41.0 (68) 2 1 
According to my answer to previous question, in my experience as a Respiratory Therapist the use of 
……………. antibiotic is prescribed for the pathogen selected in question nine-tee. 36.7 (61) 16.9 (28) 46.4 (77) 2 1 
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0= Wrong answer, 1= Right answer, 2 = I don’t know                                   
Table 4-2 – Descriptive statistics for management section. N=166 
Question Correct % (n) Wrong % (n) I don’t know % (n) Mode Median 
Management of CF        
From my experience as a Respiratory Therapist, the gold standard for airway clearance therapy in a CF 
patient is: 56.6 (94) 39.2 (65) 4.2 (7) 1 1 
From my experience as a Respiratory Therapist, the Mucoactive agent used most often with a CF patient is: 35.5 (59) 46.4 (77) 18.1 (30) 0 1 
From my experience as a Respiratory Therapist, ........... reduces the viscosity of airway secretion in general. 26.5 (44) 51.2 (85) 22.3 (37) 0 0 
From my experience as a Respiratory Therapist, the administration of Mucoactive agent should occur: 62.7 (104) 25.3 (42) 12.0 (20) 1 1 
From my experience as a Respiratory Therapist, airway clearance therapy should be performed for: 22.9 (38) 77.1 (128) -- 0 0 
From my experience as a Respiratory Therapist, airway clearance therapy in a CF patient with a small 
pneumothorax (≤3 cm) should be: 25.3 (42) 38.6 (64) 36.1 (60) 0 1 
From my experience as a Respiratory Therapist, airway clearance therapy in a CF patient with scant 
hemoptysis should be: 14.5 (24) 57.8 (96) 27.7 (46) 0 0 
From my experience as a Respiratory Therapist, aerosol therapy that induces a cough (hypertonic saline 
>0.9%) a with CF patient who has a pneumothorax should be: 20.5 (34) 41.6 (69) 38.0 63) 0 1 
From my experience as a Respiratory Therapist, BiPAP in a CF patient with scant hemoptysis should be: 18.7 (31) 45.8 (76) 35.5 (59) 0 1 
From my experience as a Respiratory Therapist, the use of hypertonic saline (>.9%) twice a day to reduce the 
chance of lung infection in a CF patient is: 39.8 (66) 26.5 (44) 33.7 (56) 1 1 
From my experience as a Respiratory Therapist, PEP therapy in a CF patient with an ear infection is: 42.2 (70) 19.3 (32) 38.6 (64) 1 1 
From my experience as a Respiratory Therapist, the airway clearance regiment AFTER lung transplant in a 
CF patient is: 24.1 (40) 24.1 (40) 51.8 (86) 2 2 
From my experience as a Respiratory Therapist, the long-term use of Dornase Alpha demonstrates better 
outcome compared to short-term use in a CF patient. 69.9 (116) 30.1 (50) -- 1 1 
From my experience as a Respiratory Therapist, the long-term use of an anti-inflammatory like inhaled 
corticosteroids to increase forced exhaled volume in 1 second (FEV1) in a CF patient is: 45.2 (75) 15.7 (26) 39.2 (65) 1 1 
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Table 4-3 – Number and percentage of the correct responses for the survey questions. N=166 
Characteristic N % 
Zero correct response 3 1.8 
One correct response 5 3 
Two correct responses 6 3.6 
Three correct responses 8 4.8 
Four correct response 12 7.2 
Five correct response 11 6.6 
Six correct response 25 15.1 
Seven correct response 16 9.6 
Eight correct response 21 12.7 
Nine correct response 12 7.2 
Ten correct response 21 12.7 
Eleven correct response 10 6.0 
Twelve correct response 8 4.8 
Thirteen correct response 5 3.0 
Fourteen correct response 2 1.2 
Fifteen correct response 1 .6 
Total 166 100 
Mode 6 Median 7 Minimum 00 Maximum 15 
 
Table 5 – Comparison of level of adherence to cystic fibrosis clinical guidelines between awareness, 
knowledge and management among Respiratory Therapists in Saudi Arabia. N=166 
      
 
Negative ranks  Positive ranks  Test statistic 
n Mean rank 
Sum of 
ranks  n 
Mean 
rank 
Sum of 
ranks  Ties Z P 
Total correct responses for 
management - Total correct 
responses for awareness & 
knowledge 
7" 19.86 139  144% 78.73 11337  15' −10.45∗ .00 
a. Total Correct Responses Management section < Total Correct Responses Awareness and knowledge section 
b. Total Correct Responses Management section > Total Correct Responses Awareness and knowledge section 
c. Total Correct Responses Management section = Total Correct Responses Awareness and knowledge section 
* Based on negative ranks. 
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Findings Related to Research Question 3 
The Third research question asked What is the effect of the level of RT’s education on 
the level of adherence to CF clinical guidelines?” A Kruskal-Wallis Test didn’t reveal a 
significant difference in the overall number of correct responses between the levels of RT 
education, H(2) = 2.7, p = .255.  So, the level of RT education did not have a significant effect 
on the level of adherence to CF clinical guidelines (see table 8).  
Findings Related to Research Question 4 
The fourth research question asked” What is the level of adherence to CF clinical 
guidelines in senior RTs compared to junior RTs. Experience was measured in term of years of 
experience and skill level as indicated by the RT’s current position. Results of the Spearman 
correlation indicated that there was a significant positive association between years of experience 
and number of overall correct responses, rs (166) = .26, p < .01; There was a significant 
association between years of experience and number of overall wrong responses, rs (166) = .16, p 
< .05; There was a significant association between years of experience and number of overall I 
don’t know responses, rs (166) = -.30, p < .01 (see table6-7). Thus, overall, respondents with 
more years of experience tent to have higher adherence level.   
A Mann-Whitney test indicated that overall, the respondents who had more than five 
years of experience answered significantly more questions correctly (Mdn = 8.5) then those who 
had less than five years of experience (Mdn = 7.0), U = 2056, p < .001, rs (166) = .314. So, 
overall, those with seniority in terms of years of experience had significantly higher adherence 
level than those without seniority (See table7).  
Kruskal-Wallis Test revealed a significant difference between the levels of current 
position in terms of the overall number of correct responses, H(6) = 12.1, p = .05. Within 
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different levels of current position, overall, supervisors (mean rank = 112.04, n = 14), those who 
were un-employed (mean rank = 111.5, n = 5) and clinical educators (mean rank =100, n = 7) 
answered greatest number of questions correctly. So, overall, there were significant differences 
in the adherence level between current positions. Specifically, those at supervisory and clinical 
educator levels and those who were un-employed had higher level of adherence (see table 8).  
Table – 6 Spearman’s rank-order correlation between years of experience and participant responses. 
N=166  
 
How many years 
of experience do 
you have in the 
field of RT?  
 
Overall correct 
responses 
Overall Wrong 
responses 
Overall, I don’t know 
responses 
How many years of 
experience do you have in 
the field of RT?  
Overall correct responses 
1.000 
 
 
.264** 
 .264** .163* -.303** 
Overall Wrong responses .163* 
Overall, I don’t know 
responses 
 
-.303** 
 
  
Table – 7 Comparison of overall correct responses between Respiratory Therapists who have > 5 years 
of experience and those who have < 5 years of experience. N=166   
Factor Overall 
Mann-Whitney U 2056 
Z-score -4.028 
Significance P-value .000 
 
**. Correlation is significant at the 0.01 level (2-tailed).              
*. Correlation is significant at the 0.05 level (2-tailed). 
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Table – 8 Comparison of the overall number of correct responses between highest levels of respiratory therapists  education, between the 
regions and current position. N=166 
Questions Overall  n H(df) P 
Region of Practice  2.5(4) .645 
Center region 86 
  
East region 40 
North region 2 
South region 8 
West region 30 
Highest level of respiratory therapy education  2.7(2) .255 
Associate degree 11 
  Bachelor degree 122 
Master degree 33 
Highest completed overall level of education  9.1(4) .053 
Associate degree 9 
  
Bachelor degree 115 
Master degree 34 
Doctorate (PhD, EdD, ScD, etc.) 6 
Doctor of Medicine 2 
Current position  12.1(6) .050 
Respiratory Therapist - Technician 14 
  
Respiratory Therapist - Specialist 100 
Respiratory Therapist - Supervisor 14 
Respiratory Therapist - Director or Manger 8 
Respiratory Therapist – Clinical Educator 7 
Respiratory Therapist – Faculty member 18 
Un employed 5 
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Findings Related to Research Question 5 
The fifth research question asked” What is the level of adherence among RTs between 
the different regions of Saudi Arabia?”  A Kruskal-Wallis Test revealed no significant difference 
in overall number of correct responses between the region of practice in Saudi Arabia, H(4) = 
2.5, p = .645 ( see table 8). So, the region which RT practice did not have significant effect on 
overall number of correct responses.  
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CHAPTER V 
Interpretation of Findings 
This chapter will present a discussion of the findings presented in Chapter IV. The 
chapter is divided into six major sections: an overview of the study, discussion of findings, 
implications for research, future research recommendations, limitations of the study, and 
conclusion. 
Overview of the Study 
This study aimed to assess the adherence level of Respiratory Therapists (RTs) to the 
cystic fibrosis (CF) clinical guidelines and determine if the RTs in Saudi Arabia are following 
the CF Foundation's clinical guidelines for the management of respiratory complication in CF 
disease. The following research questions were addressed in order to help guide the study: 
6. What is the level of adherence among Respiratory Therapists (RTs) in Saudi Arabia to 
cystic fibrosis (CF) clinical guidelines? 
7. Which section needs the most improvement concerning the level of adherence to CF 
clinical guidelines? 
8. What is the effect of the level of RT’s education on the level of adherence to CF clinical 
guidelines?   
9. What is the level of adherence to CF clinical guidelines in senior RTs compared to junior 
RTs? 
10. What is the level of adherence among RTs between the different regions of Saudi Arabia? 
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Discussion 
Findings Related to Research Question 1 
The first research question asked, "What is the level of adherence among Respiratory 
Therapists (RTs) in Saudi Arabia to cystic fibrosis (CF) clinical guidelines?" The finding showed 
that overall adherence of RTs to treat CF respiratory complication was found to be 35% on 
average, which indicates that most of RTs in Saudi Arabia do not depend on guidelines in CF 
management. The reason for low adherence level may arise due to the lack of familiarity with 
clinical guidelines or department protocols contradictory with a specific recommendation in 
guidelines (Perez et al., 2012). To improve the adherence level among healthcare provider, 
Lugtenberg et al. (2009) found that clinical guidelines should be more precise concerning the 
applicability and recommend discussing the clinical guidelines in the education curriculum as an 
innovative education strategy. 
Other Findings Related to Research Question 1 
The study finding showed that there was a significant correlation between RTs who were 
familiar with CF clinical guideline and adherence level rs =.80. Also, there was a significant 
correlation between an accredited registered Respiratory Therapist (RRT) from the national 
board of respiratory care (NBRC) and I don’t know responses rs = -.65. Overington et al. (2014) 
found healthcare providers who follow clinical guidelines, will deliver the best available care 
during their clinical practice. Parthasarathy, Subramanian, & Quan (2014), observed that 
physicians with the accreditation-certification status were associated with high clinical guidelines 
adherence, better patient education, high-grade patient satisfaction, and better timeliness. 
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Findings Related to Research Question 2 
The second research question asked, "which section needs the most improvement 
concerning the level of adherence to CF clinical guidelines?" The study showed that respondents 
have inadequate knowledge about CF disease. Respondents significantly answered more 
questions correctly in the management section (P<.001) compared to knowledge section which 
suggests a gap exists between knowledge and practice. A similar study conducted in Nigeria to 
measure the gap between knowledge and practice of providers treating uncomplicated malaria 
found that there was a gap between providers' knowledge and their practice (Mangham-Jefferies, 
Hanson, Mbacham, Onwujekwe, & Wiseman, 2015). Majumdar, McAlister, & Furberg (2004) 
found lack of motivation, lack of awareness, disagreement with the guidelines, lack of self-
efficacy and overemphasis on potential side effects can cause the gap between knowledge and 
the way of practice and management of the disease. 
Findings Related to Research Question 3 
 The third research question asked, "What is the effect of the level of RT's education on 
the level of adherence to CF clinical guidelines?" The study result showed the level of RT 
education (associate degree, bachelor's degree, and master's degree) did not have a significant 
effect on the level of adherence to CF clinical guidelines (p = .255). This finding may be due to 
the same educational background. Most of the respiratory therapy schools in Saudi Arabia are 
following the same teaching strategies and have the same curriculum (Alotaibi, 2015). There is 
no similar research support that the level of education will not alter the adherence level in the 
healthcare provider. However, Aiken, (2003) found in her study "Educational Levels of Hospital 
Nurses and Surgical Patient Mortality" that nurses with a bachelor’s degree or higher, have less 
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mortality rate compared to the nurse who has associated degree. That indicates that as the level 
of education increase, the management of disease increase, and the mortality decreased. 
Findings Related to Research Question 4 
The fourth research question asked, “What is the level of adherence to CF clinical 
guidelines in senior RTs compared to junior RTs?” Experience was measured in years and skill 
level as indicated by the RT’s current position. The study showed that there was a significant 
positive association between years of experience and number of overall correct responses, rs 
(164) = .26, p < .01 and a significant negative association between years of experience and 
number of overall, I don’t know responses, rs (164) = -.30, p < .01. That means as years of 
experience increase the adherence level and awareness level increase. (Blegen, Vaughn, & 
Goode, 2001) found units with more experienced nurses had lower medication errors and lower 
patient fall rates. However, McKinlay et al., (2007) found that there were no significant 
differences in the use of guidelines depending on physician level of experience (p = 1.0).  
Also, the study found that respondents with more than five years of experience had 
significantly more questions correctly (Mdn = 9.5) than those who had less than five years of 
experience (Mdn = 7.0), U = 2056, p < .001, rs (164) =.314. Meaning therapist with more than 
five years of experience has higher adherence level and higher management level. In a study 
conducted in the nursing field, McHugh & Lake (2010) mentioned that a higher proportion of 
nurses with ≥ five years of experience was associated with fewer medication errors and lower 
patient fall rates.  
Additionally, the study showed that there were significant differences in the number of 
correct responses between current positions. Specifically, those at supervisory and clinical 
educator levels and those who were un-employed answered most number of questions correctly. 
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Leading positions in Saudi Arabia hospital require spending a certain number of hours at the 
bedside before obtaining a supervisory position, which may explain why supervisors have more 
correct answers and better management (Slipicevic & Masic, 2012). Clinical educator job 
description required to be up to date with the new clinical guidelines, which also explains the 
high correct response with clinical educator compared to other positions (CAPCSD, 2013). Also, 
the reasons behind the high correct responses among unemployed to survey questions are; they 
are fresh graduates, they just finished internship and knowledge still fresh in their minds (Dogra, 
Mahajan, Jad, & Mahajan, 2015).  
Findings Related to Research Question 5 
The fifth research question asked, "What is the level of adherence among RTs between 
the different regions of Saudi Arabia?" The study revealed that the region which RT practice did 
not have a significant effect on the overall number of correct responses. Meaning that the region 
does not affect the overall adherence level of RTs in Saudi Arabia. Moreover, the Saudi 
Commission for Health Specialties (SCFHS) require students to complete their externship in 
accredited hospitals (SCFHS, 2014). This requirement attempts to ensure RTs knowledge is 
equivalent in all Saudi Arabia regions. Also, most of the schools that students graduate from in 
Saudi Arabia are following same teaching strategies and may help explain the lack of differences 
between the regions (Alotaibi, 2015). (Cantrell, Browne, & Lupinacci, 2005) found in her study 
that nurses who had externship requirements were more professionalism and role socialization 
compared to the nurses who had not has externship requirements. 
Implications for Research 
The finding of this study will promote the importance of adherence to CF clinical 
guidelines. This finding indicates that adherence level to clinical guidelines needs to be improved 
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among RTs in Saudi Arabia. Further education session and class are required to improve the 
overall level of adherence to clinical guidelines which can improve and enhance the management 
of CF disease and increase the average survival rate in Saudi Arabia. Moreover, the Saudi 
Respiratory schools need to consider teaching the disease management based on the updated 
published guidelines. 
Recommendation for Future Study 
Future research is recommended due to lack of research on the subject of the perception 
of adherence to cystic fibrosis guidelines by respiratory therapists in Saudi Arabia. To validate 
the results of this study, replication with larger number of participants recommended and use of 
multi-organization that has lager date base of the Respiratory Therapist like Saudi Commission 
for Health Specialties (SCFHS). 
Limitations 
The present study is limited by different factors. The findings of this study cannot be 
generalized to all RTs adherence level due to the use of only one database that has RTs 
information, and one cultural background.  Moreover, the study is limited by its relatively small 
sample size drawn from a large population of RTs. Finally, there is a lack of research in the 
perception of adherence to cystic fibrosis guidelines by respiratory therapists in Saudi Arabia.  
Conclusion 
RTs adherence to clinical guidelines plays a significant role in the management of 
respiratory complications associated with cystic fibrosis. Years of experience in the clinical field, 
RTs job position, familiarity with clinical guidelines and accreditation from NBRC were 
correlated with adherence level and quality of care. The study findings indicate that average 
adherence level of the Respiratory Therapists in Saudi Arabia is low and need to be improved. 
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Educational classes need to be conducted to improve the CF disease knowledge level in RTs. 
Also, to enhance the management level, RT departments required to keep their staff updated with 
new clinical published guidelines.
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Appendix A: The Perception of Adherence to Cystic Fibrosis Guidelines by Respiratory 
Therapists in Saudi Arabia Survey 
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I.  Demographic data.  
1. Country of citizenship: 
o (1)Canada.  
o (2)Philippines. 
o (3)Saudi Arabia.   
o (4)United States of America.  
o Other ……………... 
2. What is your gender? (1) Male/(2)Female 
3. Current age: ………… years old. 
4. Are you currently practicing respiratory care in Saudi Arabia? Yes/No 
5. At what age did you start respiratory therapy profession?......... 
6. How many years of experience do you have in the field of respiratory care? ……… 
7. In which region of Saudi Arabia do currently practicing Respiratory therapy profession? 
o (1)Center region  
o (4)East region 
o (2)North region 
o (5)South region 
o (3)West region 
8. What is your highest level of respiratory therapy education? 
o (1)Associate degree 
o (2)Bachelor degree 
o (3)Master degree  
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9.  What is your highest completed overall level of education? 
o (1)Associate degree 
o (2)Bachelor degree 
o (3)Master degree  
o (4)Doctorate (PhD, EdD, ScD, etc.) 
o (5)Doctor of Medicine 
10. What is your current position? 
o (1)Respiratory Therapist - Technician.  
o (2)Respiratory Therapy - Specialist 
o (3)Respiratory Therapist- Supervisor  
o (4)Respiratory Therapist- Director or Manger 
o (5)Respiratory Therapist- Clinical Educator 
o (6)Respiratory Therapist- Faculty member 
o Other (please specify) ………………… 
11. Have you treated a cystic fibrosis (CF) patient in the past? (1)Yes/(2)No. 
12. Are you familiar with CF foundation clinical guidelines? (1)Yes/(2)No. 
13. Are you a credentialed registered respiratory therapist (RRT) by National Board for 
Respiratory Care (NBRC) form United States of America? (1)Yes/(2)No.  
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II.  Survey  
A. Respiratory Therapists perception and awareness of CF disease. 
1. From my experience as a Respiratory Therapist, sweat chloride of ……... mmol/l or more 
can indicate the presence of CF. 
o (1)40  
o (2)60  
o (3)100  
o (4)I don't know 
2. From my experience as a Respiratory Therapist, performing direct spirometry test for an 
adult patient with CF disease, the predicted value for forced exhaled volume in one 
second (FEV1) will be ……… 
o (1)more than 60% 
o (2)less than 60%.  
o (3)I don't know 
3. From my experience as a Respiratory Therapist, most CF chest x-ray 
demonstrate……….….. lungs. 
o (1)wet  
o (2)collapsed  
o (3)hyperinflated 
o (4)I don't know 
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4. From my experience as a Respiratory Therapist, CF inflammatory response is ……. 
relative to the burden of infection. 
o (1)excessive  
o (2)minimum  
o (3)I don't know 
5. From my experience as a Respiratory Therapist, ……………... is the most common 
destructive airway pathogen present in CF patients. 
o (1)staphylococcus aureus 
o (2)hemophilus Influenza 
o (3)pseudomonas aeruginosa 
o (4)escherichia coli 
o (5)I don't know 
6. According to my answer to question five, in my experience as a Respiratory Therapist the 
use of ……………. antibiotic is prescribed for the pathogen selected in question five 
pathogen. 
o (1)inhaled Cephalexin 
o (3)inhaled Tobramycin 
o (2)inhaled Moxifloxacin. 
o (4)I don't know 
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B. RTs Perception of CF disease management. 
1. From my experience as a Respiratory Therapist, the Mucoactive agent that used most 
often with cystic fibrosis patients is:  
o (1)Dornase Alpha. 
o (2)N-acytlecystine 
o (3)Hypertonic saline.  
o (4)I don’t know 
2. From my experience as a Respiratory Therapist, the gold standard for airway clearance 
therapy in CF patients is:  
o (1)High-frequency chest wall oscillation (chest vest). 
o (2)Autogenic drainage. 
o 93)Chest physiotherapy (manual CPT) 
o (4)I don’t know 
3. From my experience as a Respiratory Therapist, ........... reduces the viscosity of airway 
secretion in general.……………...  
o (1)Albuterol Sulfate 
o (3)N-Acetylcysteine 
o (2)Dornase Alpha 
o (4)Normal saline. 
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4. From my experience as a Respiratory Therapist, the administration of Mucoactive agent 
should occur: 
o (1)Before physiotherapy 
o (2)During physiotherapy 
o (3)After physiotherapy 
o (4)I don’t know 
5. From my experience as a Respiratory Therapist, airway clearance therapy should 
be performed for: 
o (1)10 - 19 minutes 
o  (2) 20 - 40 minutes 
o (3) 41 - 60 minutes 
6.  From my experience as a Respiratory Therapist, airway clearance therapy in CF patients 
with a small pneumothorax (≤3 cm) should be: 
o (1)Stopped. 
o (2)Not stopped 
o (3)I don’t know 
7. From my experience as a Respiratory Therapist, the airway clearance therapies in CF 
patients with scant hemoptysis should be: 
o (1)Stopped. 
o (2)Not stopped 
o (3)I don’t know 
 
 49 
8. From my experience as a Respiratory Therapist, aerosol therapy that induces a cough 
(hypertonic saline >0.9%) with CF patients who has a pneumothorax should be: 
o (1)Stopped  
o (2)Not stopped  
o (3)I don’t know 
9. From my experience as a Respiratory Therapist, BiPAP in CF patients with scant 
hemoptysis should be: 
o (1)Stopped  
o (2)Not stopped  
o (3)I don’t know 
10. From my experience as a Respiratory Therapist, the use of hypertonic saline (>.9%) twice 
a day to reduce the chance of lung infection in CF patients is: 
o (1)Indicated   
o (2)Not Indicated  
o (3)I don’t know  
11. From my experience as a Respiratory Therapist, PEP therapy in CF patients with an ear 
infection is: 
o (1)Indicated  
o (2)Not indicated 
o (3)I don’t know 
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12. From my experience as a Respiratory Therapist, the airway clearance regiment AFTER 
lung transplant in CF patients is: 
o (1)Indicated  
o (2)Not indicated  
o (3)I don’t know 
 
13. From my experience as a Respiratory Therapist, the long-term use of anti-inflammatory 
like inhaled corticosteroids to increase forced exhaled volume in one second (FEV1) in 
CF patients is: 
o (1)Indicated  
o (2)Not indicated  
o (3)I don't know 
14. From my experience as a Respiratory Therapist, the long-term use of Dornase Alpha 
demonstrated better outcome compared to short-term use in CF patients.   
o (1)Yes 
o (2)No  
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Appendix B: First Cover Letter 
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Dear SSRC member, 
You are invited to participate in a research study titled " The Perception of Adherence to 
Cystic Fibrosis Guidelines by Respiratory Therapists in Saudi Arabia." The research study will 
explore Respiratory Therapist perception of management of respiratory complications associate 
Cystic Fibrosis disease. The research is being conducted by Jameel Hakeem, a Master student at 
Georgia State University, under the direction of Dr. Doug Gardenhire, Chair of the Department 
of Respiratory Therapy. Your involvement in this research study is voluntary, and if you refuse 
to take the survey you can submit a blank survey by select the disagree option. All responses are 
confidential. No names or codes will be used to identify responses. All results will be deleted 
after they have been collected.  
Findings will be published based on groups, not individuals. If you would like a summary 
of the work or if you have any questions about this research, please contact Jameel Hakeem at 
jhakeem1@student.gsu.edu or Dr. Doug Gardenhire at dgardenhire@gsu.edu. The 
department's contact information can be found at the bottom of this page.  
Best regard,  
Jameel Hakeem 
Department of Respiratory Therapy 
Georgia State University 
P.O. Box 4019 
Atlanta, GA 30302 
(619) 430-7021 
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Appendix C: Second Cover Letter 
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Dear SSRC member, 
We understand you are very busy. So, we wanted to remind you that we still kindly need 
your assistance. Last week we sent you an online survey to complete. The purpose of the 
research study is to explore Respiratory Therapist perception of management of respiratory 
complications associate Cystic Fibrosis disease. If you have responded to the survey thank you 
so much for your time. If you have not, I am writing you again because I still need your help to 
successfully complete this research study. The survey should not take more than 10 minutes of 
your time. We would like to ask you please to complete the survey today by clicking on the link 
below: If you have any questions about this research, now or in the future, please contact Jameel 
Hakeem at jhakeem1@student.gsu.edu or Dr. Doug Gardenhire at dgardenhire@gsu.edu The 
department's contact information can be found at the bottom of this page. 
Best Regards, 
Jameel Hakeem 
Department of Respiratory Therapy 
Georgia State University 
P.O. Box 4019 
Atlanta, GA 30302 
(619) 430-7021 
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Appendix D: Final Follow-Up Letter 
 
  
 56 
Dear SSRC member, 
We understand you are very busy. So, we wanted to remind you that we still kindly need 
your assistance. About two weeks ago, we sent you an online survey to complete. The purpose of 
the research study is to explore Respiratory Therapist perception of management of respiratory 
complications associate Cystic Fibrosis disease. If you have responded to the survey thank you 
so much for your time. If you have not, I am writing you again because I still need your help to 
successfully complete this research study. The survey should not take more than 10 minutes of 
your time. We would like to ask you please to complete the survey today by clicking on the link 
below: If you have any questions about this research, now or in the future, please contact Jameel 
Hakeem jhakeem1@student.gsu.edu or Dr. Doug Gardenhire at dgardenhire@gsu.edu The 
department's contact information can be found at the bottom of this page.  
Best Regards, 
Jameel Hakeem 
Department of Respiratory Therapy 
Georgia State University 
P.O. Box 4019 
Atlanta, GA 30302 
(619) 430-7021 
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